New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets

BACKGROUND: The urgent medical need for innovative approaches to control influenza is emphasized by the widespread resistance of circulating subtype H1N1 viruses to the leading antiviral drug oseltamivir, the pandemic threat posed by the occurrences of human infections with highly pathogenic avian H...

Descripción completa

Detalles Bibliográficos
Autores principales: Friesen, Robert H. E., Koudstaal, Wouter, Koldijk, Martin H., Weverling, Gerrit Jan, Brakenhoff, Just P. J., Lenting, Peter J., Stittelaar, Koert J., Osterhaus, Albert D. M. E., Kompier, Ronald, Goudsmit, Jaap
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817000/
https://www.ncbi.nlm.nih.gov/pubmed/20161706
http://dx.doi.org/10.1371/journal.pone.0009106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817000/
https://www.ncbi.nlm.nih.gov/pubmed/20161706
http://dx.doi.org/10.1371/journal.pone.0009106

Ejemplares similares